Conversations on COVID-19: Finding Antibodies to Fight SARS-CoV-2

Tuesday, February 23, 2021
11:00am to 11:45am
Add to Cal
Online Event

Caltech researchers at every level, from undergraduates to faculty members to JPL engineers, jumped into action when the COVID-19 pandemic struck. Their work continues to advance our understanding of the virus and to accelerate progress toward solutions as they develop treatments to decrease fatality rates, create diagnostics crucial to controlling the virus's spread, and engineer models that policymakers rely on in public health decision-making.

Hear directly from Caltech researchers about their progress and ask your own questions in this series of conversations for the Caltech community.

Christopher O. Barnes, Senior Postdoctoral Fellow in Biology and Biological Engineering and Howard Hughes Medical Institute Hanna Gray Fellow
in conversation with
Lori Dajose (BS '15), Content and Media Strategist, Office of Strategic Communications

About the Participants

Christopher O. Barnes is a Howard Hughes Medical Institute (HHMI) Hanna Gray Postdoctoral Fellow in the Bjorkman Lab at Caltech, where he uses high-resolution imaging techniques to investigate how viruses infect humans, and how the body's immune system responds to viral infections. He focuses on antibodies to neutralize HIV-1 and, more recently, SARS-CoV-2.

Lori Dajose is a content strategist and science writer in Caltech's Office of Strategic Communications covering biology, bioengineering, and neuroscience. Lori received her undergraduate degree from Caltech in 2015 and began working in OSC shortly afterward. As a planetary science major, she didn't have much exposure to the biological sciences but enjoys learning new things every day at work.

► REGISTER NOW

This series is presented by the Caltech Science Exchange, which brings expert insight to the scientific questions that define our time. The Science Exchange offers trustworthy answers, clear explanations, and fact-driven conversation on critical topics in science and technology, including COVID-19 and other viruses.